Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N. Goetz CG, et al. Among authors: lang ae. Mov Disord. 2007 Jan;22(1):41-7. doi: 10.1002/mds.21198. Mov Disord. 2007. PMID: 17115387
Toward a redefinition of Parkinson's disease.
Stern MB, Lang A, Poewe W. Stern MB, et al. Mov Disord. 2012 Jan;27(1):54-60. doi: 10.1002/mds.24051. Mov Disord. 2012. PMID: 22252891 No abstract available.
A double-blind, delayed-start trial of rasagiline in Parkinson's disease.
Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E; ADAGIO Study Investigators. Olanow CW, et al. N Engl J Med. 2009 Sep 24;361(13):1268-78. doi: 10.1056/NEJMoa0809335. N Engl J Med. 2009. PMID: 19776408 Free article. Clinical Trial.
Editorial.
Lang A, Lees A. Lang A, et al. Mov Disord. 2002 Jan;17(1):1-2. doi: 10.1002/mds.10108. Mov Disord. 2002. PMID: 28650126 No abstract available.
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.
Rascol O, Fitzer-Attas CJ, Hauser R, Jankovic J, Lang A, Langston JW, Melamed E, Poewe W, Stocchi F, Tolosa E, Eyal E, Weiss YM, Olanow CW. Rascol O, et al. Lancet Neurol. 2011 May;10(5):415-23. doi: 10.1016/S1474-4422(11)70073-4. Epub 2011 Apr 7. Lancet Neurol. 2011. PMID: 21482191 Clinical Trial.
1,131 results